Keywords: ucb, gets, expanded, xyrem, marketing, license, jazz

UCB gets expanded Xyrem marketing license by Jazz

Article | 09 October 2006

Print This

Belgian drugmaker UCB and the USA's Jazz Pharmaceuticals have signed an expanded product license agreement for Xyrem (sodium oxybate). Under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in